Spacing Out GLP-1 Doses: A New Frontier in Weight Loss Maintenance
Spacing Out GLP-1 Doses: A New Frontier in Weight Loss Maintenance The commercial debut of GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) has fundamentally revolutionized modern obesity medicine. Yet, for millions of individuals who have successfully shed weight on these medications, a massive personal question looms over their success: “Am I … Read more